comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 16:35:44 - browse：957

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Behind warning on Apellis’s eye drug lies a conflict of interest

focus

WSS

Oak trusses raised to roof of fire

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Oak trusses raised to roof of fire

Public health communication lessons from Covid

Ending health disparities requires full federal government, panel says

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

hotspot

comprehensive

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Drug repurposing or repositioning? The language matters

As the dark side of IVF slowly comes into focus, even more transparency is needed

Medicare proposal to cover medical devices draws a mixed reaction

Iowa House, Senate pass 6

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

California’s proposed $25 per hour health care minimum wage

Medicare details structure of new drug price negotiation program

NIH fellows want a pay raise. Will that mean less money for grants?

hotspot

It's time to get medical device identifiers over the finish line

Iowa House, Senate pass 6

Why ADHD is under

CDC: Cases of alpha

Timeline: Special counsel's probe into Trump's handling of classified documents

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

leisure time

focus

focus

explore